Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the expense of this innovative drug and its supply have become key issues for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant barrier to man